Metraipolis › archive › dc_fc4e1881d974

K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation — Europe PMC PMID:40550849

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40550849
DOI
10.1038/s41598-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-08T13:43:53.199Z
SHA-256 of the archived text
b7d69bc1d45900a8b92b529ab603248b3cbdc0819953f05e24a9b088d4f3840c
Stable URL of this page
https://metraipolis.com/documento/dc_fc4e1881d974

How to cite

K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation — Europe PMC PMID:40550849 — Europe PMC (en), https://europepmc.org/article/MED/40550849 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fc4e1881d974 (Metraipolis archive dc_fc4e1881d974, sha256 b7d69bc1d45900a8b92b529ab603248b3cbdc0819953f05e24a9b088d4f3840c)
BibTeX
@misc{dcfc4e1881d974,
  title = {K36-based inhibitor analogs as potential therapeutics against SARS-CoV-2 main protease (Mpro): a computational investigation — Europe PMC PMID:40550849},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40550849},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fc4e1881d974; sha256 b7d69bc1d45900a8b92b529ab603248b3cbdc0819953f05e24a9b088d4f3840c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40550849. Agents can read the archived copy with the MCP tool read_document.